About Medicure
Medicure is a company based in Winnipeg (Canada) founded in 1997 by Albert D Friesen. The company has 23 employees as of December 31, 2024. Medicure has completed 2 acquisitions, including Apicore and Marley Drug. Medicure offers products and services including AGGRASTAT and Zypitamag.
- Headquarter Winnipeg, Canada
- Employees 23 as on 31 Dec, 2024
- Founders Albert D Friesen
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medicure Inc.
-
Annual Revenue
$15.23 M (USD)0.98as on Dec 31, 2024
-
Net Profit
-$722.81 K (USD)-12.69as on Dec 31, 2024
-
EBITDA
-$293.99 K (USD)-132.14as on Dec 31, 2024
-
Latest Funding Round
$44.65 M (USD), Debt – Conventional
Nov 18, 2016
-
Investors
Crown Capital Partners
& 1 more
-
Employee Count
23
as on Dec 31, 2024
-
Investments & Acquisitions
Apicore
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medicure
Medicure is a publicly listed company on the TSXV with ticker symbol MPH in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medicure
Medicure offers a comprehensive portfolio of products and services, including AGGRASTAT and Zypitamag.
AGGRASTAT is provided as a therapeutic injection for cardiovascular conditions, contributing to patient care through its commercialization.
Zypitamag is offered as a medication within the growing portfolio, aimed at addressing health needs in the U.S. market.
People of Medicure
Unlock access to complete
Funding Insights of Medicure
Investors in Medicure
Medicure has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Crown Capital Partners and CentreStone Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund focused on life sciences is operated.
|
Locked | Locked | Locked | |
|
Distributed power and broadband network solutions are developed.
|
Locked | Locked | Locked |
Investor details for Medicure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medicure
Medicure has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Apicore and Marley Drug.
Investment portfolio details for Medicure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
APIs are manufactured and custom synthesis services are provided.
|
Locked | Locked | 2004 | Locked | |
|
Supplier of pharmaceutical products
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Medicure
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Medicure
Detailed financials for Medicure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medicure Comparisons
Peer comparison for Medicure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medicure
Detailed competitors of Medicure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medicure
Complete news archive for Medicure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicure
Medicure was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Medicure is headquartered in Winnipeg, Canada. It is registered at Winnipeg, Manitoba, Canada.
Albert D Friesen is the current CEO of Medicure. They have also founded this company.
As of Dec 31, 2024, the latest employee count at Medicure is 23.
Annual revenue of Medicure is $15.23M as on Dec 31, 2024.
Medicure was founded in 1997 in Winnipeg, Canada, within the pharmaceutical sector. Innovative and affordable medications are developed and commercialized by the company. An online pharmacy platform is operated to fulfill prescriptions and deliver a range of medications. Products are marketed to healthcare professionals and consumers via e-commerce channels. Operations center on therapeutics development and prescription services in Canada.
Medicure offers AGGRASTAT and Zypitamag.
Yes, Medicure is publicly traded on TSXV under the ticker symbol MPH.
Medicure has made 2 acquisitions, including Apicore, and Marley Drug.
Medicure has 2 investors. Key investors include Crown Capital Partners, and CentreStone Ventures.
The ticker symbol of Medicure is MPH on TSXV.